Reconstitution of Human Necrosome Interactions in Saccharomyces cerevisiae

• Published in: Biomolecules (Basel, Switzerland) Vol. 11; no. 2; p. 153
• Main Authors: Ji, Y, Ward, L A, Hawkins, C J
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 25.01.2021; MDPI
• Subjects: Apoptosis; Cell death; Cloning; kinase; Kinases; Lethality; MAP kinase; Microscopy; Mutation; necroptosis; phosphorylation; Plasma; Plasmids; Protein interaction; Protein kinase; Protein-serine/threonine kinase; Proteins; RHIM; RIP; S. cerevisiae; Toxicity; Tumor necrosis factor-TNF; United States > US; kinase; necroptotic inhibitor; overexpression; subcellular localization; RIP; RHIM; phosphorylation; yeast; S. cerevisiae; necroptosis
• ISSN: 2218-273X; 2218-273X
• DOI: 10.3390/biom11020153

The necrosome is a large-molecular-weight complex in which the terminal effector of the necroptotic pathway, Mixed Lineage Kinase Domain-Like protein (MLKL), is activated to induce necroptotic cell death. The precise mechanism of MLKL activation by the upstream kinase, Receptor Interacting Serine/Threonine Protein Kinase 3 (RIPK3) and the role of Receptor Interacting Serine/Threonine Protein Kinase 1 (RIPK1) in mediating MLKL activation remain incompletely understood. Here, we reconstituted human necrosome interactions in yeast by inducible expression of these necrosome effectors. Functional interactions were reflected by the detection of phosphorylated MLKL, plasma membrane permeabilization, and reduced proliferative potential. Following overexpression of human necrosome effectors in yeast, MLKL aggregated in the periphery of the cell, permeabilized the plasma membrane and compromised clonogenic potential. RIPK1 had little impact on RIPK3/MLKL-mediated yeast lethality; however, it exacerbated the toxicity provoked by co-expression of MLKL with a RIPK3 variant bearing a mutated RHIM-domain. Small molecule necroptotic inhibitors necrostatin-1 and TC13172, and viral inhibitors M45 (residues 1-90) and BAV_Rmil, abated the yeast toxicity triggered by the reconstituted necrosome. This yeast model provides a convenient tool to study necrosome protein interactions and to screen for and characterize potential necroptotic inhibitors.